Mather Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $390K | Buy |
4,988
+846
| +20% | +$66.2K | ﹤0.01% | 435 |
|
|
2025
Q1 | $300K | Buy |
4,142
+450
| +12% | +$32.6K | ﹤0.01% | 485 |
|
|
2024
Q4 | $273K | Buy |
3,692
+231
| +7% | +$17.1K | ﹤0.01% | 482 |
|
|
2024
Q3 | $228K | Sell |
3,461
-1,609
| -32% | -$106K | ﹤0.01% | 532 |
|
|
2024
Q2 | $484K | Buy |
5,070
+1,811
| +56% | +$173K | 0.01% | 423 |
|
|
2024
Q1 | $248K | Sell |
3,259
-1,769
| -35% | -$135K | ﹤0.01% | 480 |
|
|
2023
Q4 | $383K | Sell |
5,028
-395
| -7% | -$30.1K | 0.01% | 397 |
|
|
2023
Q3 | $376K | Buy |
5,423
+374
| +7% | +$25.9K | 0.01% | 386 |
|
|
2023
Q2 | $476K | Buy |
+5,049
| New | +$476K | 0.01% | 357 |
|
|
2022
Q4 | – | Sell |
-4,865
| Closed | -$402K | – | 488 |
|
|
2022
Q3 | $402K | Buy |
+4,865
| New | +$402K | 0.01% | 317 |
|
|
2022
Q2 | – | Sell |
-7,182
| Closed | -$846K | – | 412 |
|
|
2022
Q1 | $846K | Buy |
+7,182
| New | +$846K | 0.02% | 194 |
|